ATE278029T1 - Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression - Google Patents

Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression

Info

Publication number
ATE278029T1
ATE278029T1 AT99903600T AT99903600T ATE278029T1 AT E278029 T1 ATE278029 T1 AT E278029T1 AT 99903600 T AT99903600 T AT 99903600T AT 99903600 T AT99903600 T AT 99903600T AT E278029 T1 ATE278029 T1 AT E278029T1
Authority
AT
Austria
Prior art keywords
gene expression
vector
promoter
coding sequence
retroviral vector
Prior art date
Application number
AT99903600T
Other languages
English (en)
Inventor
Walter Guenzburg
Dieter Klein
Walter Tabotta
Brian Salmons
Original Assignee
Inst Virologie Teilrechtsfaehi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Virologie Teilrechtsfaehi filed Critical Inst Virologie Teilrechtsfaehi
Application granted granted Critical
Publication of ATE278029T1 publication Critical patent/ATE278029T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99903600T 1998-01-06 1999-01-03 Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression ATE278029T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK598 1998-01-06
PCT/EP1999/000002 WO1999035280A1 (en) 1998-01-06 1999-01-03 Reconstituting retroviral vector (recon vector) for targeted gene expression

Publications (1)

Publication Number Publication Date
ATE278029T1 true ATE278029T1 (de) 2004-10-15

Family

ID=8088665

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99903600T ATE278029T1 (de) 1998-01-06 1999-01-03 Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression

Country Status (7)

Country Link
US (1) US6821776B1 (de)
EP (1) EP1045922B1 (de)
AT (1) ATE278029T1 (de)
AU (1) AU2419599A (de)
DE (1) DE69920659T2 (de)
ES (1) ES2229674T3 (de)
WO (1) WO1999035280A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3908274B2 (ja) 1995-03-09 2007-04-25 ゲーエスエフ−フォルシュンクスツェントラム・フュア・ウムベルト・ウント・ゲズントハイト・ゲーエムベーハー 遺伝子治療用の抗菌ペプチドをコードする治療用遺伝子を有するベクター
AU2001263160A1 (en) 2000-05-19 2001-12-03 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution
JP2004535151A (ja) * 2000-10-10 2004-11-25 インスティトゥート フューア ヴィロロギー タイルレヒツフェヒゲス インスティトゥート アン デア ヴェテリネーアメディツィニーシェン ウニヴェルズィテート ヴィーン ウイルス性成分の活性および／または特異性の評価に対する新システム
EP1273309A1 (de) * 2001-07-05 2003-01-08 Georg-August Universität Göttingen Gentherapeutisches Verfahren zur Behandlung von GnRH-Rezeptor-positiven Karzinomen durch GnRH induzierte tumorzellspezifische Aktivierung eines therapeutischen Gens, zugehörige Nukleinsäurekonstrukte und Vektoren
WO2003004063A1 (de) * 2001-07-05 2003-01-16 Georg-August Universität Göttingen Gentherapeutisches verfahren zur behandlung von gnrh-rezeptor-positiven karzinomen durch gnrh induzierte tumorzellspezifische aktivierung eines therapeutischen gens, zugehörige nukleinsäurekonstrukte und vektoren
US20090214496A1 (en) * 2006-01-30 2009-08-27 Licentia Ltd. Bmx/etk tyrosine kinase gene therapy materials and methods
EP3317416A4 (de) * 2015-07-01 2018-12-26 The Regents of The University of California Retrovirale vektoren mit einem humanen ubiquitin-promoter mit umkehrausrichtung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658775A (en) 1988-05-17 1997-08-19 Sloan-Kettering Institute For Cancer Research Double copy retroviral vector
ATE142268T1 (de) * 1988-05-17 1996-09-15 Sloan Kettering Inst Cancer Retroviraler vektor
JP4037446B2 (ja) * 1994-09-02 2008-01-23 ゲーエスエフ − フォルシュンクスツェントルム・フューア・ウムベルト・ウント・ゲズントハイト・ゲーエムベーハー 非自己不活化性の発現標的化レトロウイルスベクタ
JP3908274B2 (ja) * 1995-03-09 2007-04-25 ゲーエスエフ−フォルシュンクスツェントラム・フュア・ウムベルト・ウント・ゲズントハイト・ゲーエムベーハー 遺伝子治療用の抗菌ペプチドをコードする治療用遺伝子を有するベクター
ATE214101T1 (de) 1995-09-06 2002-03-15 Austrian Nordic Biotherapeutic Expression von heterologen genen in menschlichen brustzellen, einschliesslich menschliche brustkarzionomzellen unter der kontrolle von regulatorischen sequenzen von wap oder mmtv

Also Published As

Publication number Publication date
AU2419599A (en) 1999-07-26
ES2229674T3 (es) 2005-04-16
EP1045922B1 (de) 2004-09-29
EP1045922A1 (de) 2000-10-25
WO1999035280A1 (en) 1999-07-15
DE69920659D1 (de) 2004-11-04
US6821776B1 (en) 2004-11-23
DE69920659T2 (de) 2006-03-09

Similar Documents

Publication Publication Date Title
Ohkawa et al. Importance of independence in ribozyme reactions: kinetic behavior of trimmed and of simply connected multiple ribozymes with potential activity against human immunodeficiency virus.
FI951404A0 (fi) Adenovirusvektoreita vieraiden geenien siirtämiseksi keskushermostojärjestelmän, erityisesti aivojen, soluihin
IL110182A0 (en) Retroviral carrier for the transference and introduction of genes for therapeutic aims into eukaryotic cells
DE69830663D1 (de) Nicht-primaten lentivirale vektoren und verpackungssysteme
ATE553205T1 (de) Verwendung von dns-sequenzen mit triplex-structur zum transfer von nukleotidsequenzen
EP0267851A3 (en) Hybrid promoter, expression controlling dna sequence and expression vector
PL319512A1 (en) Viral material and nucleotidic fragments associated with sclerosis multiplex or diagnostic, prophylactic and therapeutic purposes
HU9403788D0 (en) Self-stabilized oligonucleotides as therapeutic agents
CY1106216T1 (el) 5´ ESTs ΓΙΑ ΜΗ ΙΣΤΟ-ΕΙΔΙΚΕΣ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ
DE69920659D1 (de) Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression
WO1997022695A3 (fr) Sequences nucleotidiques, proteines, medicaments et agents diagnostiques utiles dans le traitement du cancer
JP4037446B2 (ja) 非自己不活化性の発現標的化レトロウイルスベクタ
DK0630409T3 (da) Defekt-pakkende ikke-onkovirus-vektorer baseret på MPMV
IL117194A0 (en) Amplifying sequences vectors comprising them and their uses in compositions for the expression of nucleotide sequences and pharmaceutical compositions containing them
CA2202519A1 (en) Cloning, expression and characterization of a new form of phosphatidylinositol-3-kinase
BR9815285A (pt) Vetores alfavìrus para vacina de paramixovìrus
DK0817858T3 (da) Vektorer, som indeholder terapeutiske gener for antimikrobielle peptider, til anvendelse ved genterapi
BR9714034A (pt) Sequências de consenso de origem de replicação de dna de mamìfero ou de humano,processo para o controle de iniciação de dna para a manutenção de constructos de plasmìdeo circular e de dna adequada para a inclusão em vetores de cromossoma artificial de humano e de mamìfero ou para terapia genética, processos para o controle de iniciação da replicação de dna de mamìfero e de inibição de replicação de dna in vitro ou in vivo, proteìna que se liga em dna de dupla fita, anti-gene para replicação de dna, e, uso de uma sequência.
ATE552887T1 (de) Tumorspezifischer vektor für die gentherapie
WO2002086064A3 (en) Inducible expression of transfected genes
EP1264892A3 (de) Lentivirale Vektoren mit Endothelzellen spezifischen Promotoren
ZA941287B (en) Expression constructs containing HIV inhibitory antisense and other nucleotide sequences, retroviral vectors and recombinant retroviruses containing same.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1045922

Country of ref document: EP

REN Ceased due to non-payment of the annual fee